Linkin Park frontman Chester Bennington reportedly had a trace amount of alcohol in his system at the time of his death – but his bandmate Mike Shinoda has denied that drugs played any part in his death.
Bennington passed away in July after taking his own life. He was 41.
Now, TMZ has obtained Bennington’s autopsy, which appears to indicate that the singer had a small amount of alcohol in his system at the time of his death. Authorities are also said to have found a bottle of prescription drug Zolpidem on Bennington’s dresser. He had a history of depression.
However, his bandmate Mike Shinoda then denied initial and false reports that Bennington had MDMA in his system when he took his own life.
“Just clearing this up: TMZ erroneously printed CB had MDMA in his system when he passed,” wrote Shinoda. “That was incorrect, they misread the report. They have since corrected their piece, see below. I hope other publications have the decency to do the same.”
In October, the likes of System Of A Down and Blink-182 joined Linkin Park for an all-star tribute gig dedicated to the Bennington at the Hollywood Bowl in Los Angeles.
Linkin Park also recently announced a new live album in memory of Bennington. ‘One More Light Live’ will include live recordings taken from Bennington’s final tour with the band in support of this year’s ‘One More Light’ album. It features Stormzy and will be released on December 15.
FOR HELP AND ADVICE ON MENTAL HEALTH:
- YOUNG MINDS – The voice for young people’s health and wellbeing
- CALM – The Campaign Against Living Miserably for young men
- Time To Change – Let’s end mental health discrimination
- The Samaritans – Confidential support 24 hours a day